Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 11
Submit an article Journal homepage
140
Views
9
CrossRef citations to date
0
Altmetric
Review

Nm23-H1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis

BuHyun Youn Assistant Professor Pusan National University, College of Natural Sciences, Division of Biological Sciences, Busan, 609-735, Korea
, PhD,
Hag Dong Kim Research Professor Korea University, School of Life Sciences & Biotechnology and BioInstitute, Seoul, 136-713, Korea
, PhD &
Joon Kim Professor Korea University, School of Life Sciences & Biotechnology and BioInstitute, Seoul, 136-713, Korea +82 2 3290 3442; +82 2 927 9028; [email protected]
, PhD
Pages 1419-1430 | Published online: 14 Oct 2008

Bibliography

  • Cancer Fact & Figures 2008. Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf [Last accessed 26 September 2008]
  • Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ. to invasive breast cancer. Cancer 2008;112(10):2130-42
  • Parkin DM, Bray FI, Devesa SS, et al. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):S4-66
  • Stanford JL, Herrinton LJ, Schwartz SM, et al. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 1995;6(2):181-3
  • Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71(4):1258-65
  • Carter CL, Corle DK, Micozzi MS, et al. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128(3):467-77
  • Lakhani SR, Chaggar R, Davies S, et al. Genetic alterations in normal luminal and myoepithelial cells of the breast. J Pathol 1999;189(4):496-503
  • O'Connell P, Pekkel V, Fuqua SA, et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90(9):697-703
  • Hwang ES, DeVries S, Chew KL, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 2004;10(15):5160-7
  • Buerger H, Simon R, Schafer KL, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000;53(3):118-21
  • Simpson JF, Quan DE, O'Malley F, et al. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 1997;151(1):161-8
  • Buerger H, Mommers EC, Littmann R, et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 2001;194(2):165-70
  • Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 2001;195(4):415-21
  • Banerjee S, Dowsett M, Ashworth A, et al. Mechanisms of disease: angiogenesis and the management of breast cancer. Nat Clin Pract Oncol 2007;4(9):536-50
  • Hanahan D, Christofori G, Naik P, et al. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 1996;32A14:2386-93
  • Skobe M, Rockwell P, Goldstein N, et al. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997;3(11):1222-7
  • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285(21):1182-6
  • von Tell D, Armulik A, Betsholtz C, et al. Pericytes and vascular stability. Exp Cell Res 2006;312(5):623-9
  • Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23(5):1011-27
  • Rafii S, Lyden D, Benezra R, et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy Nat Rev Cancer 2002;2(11):826-35
  • Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3(6):401-10
  • Mandriota SJ, Seghezzi G, Vassalli JD, et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995;270(17):9709-16
  • Pepper MS, Ferrara N, Orci L, et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181(2):902-6
  • Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998;273(46):30336-43
  • Harmey JH, Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays 2002;24(3):280-3
  • Tran J, Master Z, Yu JL, et al. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 2002;99(7):4349-54
  • Gerber HP, Kowalski J, Sherman D, et al. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. Cancer Res 2000;60(22):6253-8
  • Rak J, Mitsuhashi Y, Sheehan C, et al. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res 2000;60(2):490-8
  • Grugel S, Finkenzeller G, Weindel K, et al. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 1995;270(43):25915-9
  • Mazure NM, Chen EY, Laderoute KR, et al. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997;90(9):3322-31
  • Volpert OV, Dameron KM, Bouck N, et al. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene 1997;14(12):1495-502
  • Enholm B, Paavonen K, Ristimaki A, et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14(20):2475-83
  • Ogiso Y, Hwang YW, Shih TY, et al. Biological activity of a K-ras mutant that contains the 12R/59T/116Y mutations. Cancer Lett 1993;75(1):19-26
  • Larcher F, Robles AI, Duran H, et al. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res 1996;56(23):5391-6
  • Kimbro KS, Simons JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006;13(3):739-49
  • Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235(4785):177-82
  • Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353(16):1659-72
  • Wen XF, Yang G, Mao W, et al. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene 2006;25(52):6986-96
  • Klos KS, Wyszomierski SL, Sun M, et al. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res 2006;66(4):2028-37
  • Ciardiello F, Caputo R, Bianco R, et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 2001;7(5):1459-65
  • Sini P, Wyder L, Schnell C, et al. The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade. Clin Cancer Res 2005;11(12):4521-32
  • Izumi Y, Xu L, di Tomaso E, et al. Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature 2002;416(6878):279-80
  • Sweeney CJ, Miller KD, Sissons SE, et al. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res 2001;61(8):3369-72
  • Browder T, Butterfield CE, Kraling BM, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000;60(7):1878-86
  • Klement G, Baruchel S, Rak J, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000;105(8):R15-24
  • Man S, Bocci G, Francia G, et al. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 2002;62(10):2731-5
  • Bocci G, Nicolaou KC, Kerbel RS, et al. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 2002;62(23):6938-43
  • Hamano Y, Sugimoto H, Soubasakos MA, et al. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res 2004;64(5):1570-4
  • Bocci G, Francia G, Man S, et al. Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci USA 2003;100(22):12917-22
  • Kerr DJ. Targeting angiogenesis in cancer: clinical development of bevacizumab. Nat Clin Pract Oncol 2004;1(1):39-43
  • van der Geer P, Hunter T, Lindberg RA, et al. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994;10:251-337
  • Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995;129(4):895-8
  • Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307(5706):58-62
  • Tozer GM, Kanthou C, Baguley BC, et al. Disrupting tumour blood vessels. Nat Rev Cancer 2005;5(6):423-35
  • Indraccolo S, Gola E, Rosato A, et al. Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells. Gene Ther 2002;9(13):867-78
  • Gasparini G, Longo R, Toi M, et al. Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol 2005;2(11):562-77
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57-70
  • Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3(1):55-63
  • Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12(2):89-96
  • Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80(3):200-4
  • Lacombe ML, Wallet V, Troll H, et al. Functional cloning of a nucleoside diphosphate kinase from Dictyostelium discoideum. J Biol Chem 1990;265(17):10012-8
  • Wallet V, Mutzel R, Troll H, et al. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 1990;82(14):1199-202
  • Lacombe ML, Milon L, Munier A, et al. The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000;32(3):247-58
  • Agarwal RP, Robison B, Parks RE Jr, et al. Nucleoside diphosphokinase from human erythrocytes. Methods Enzymol 1978;51:376-386
  • de la Rosa A, Williams RL, Steeg PS, et al. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 1995;17(1):53-62
  • Gilles AM, Presecan E, Vonica A, et al. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266(14):8784-9
  • Garces E, Cleland WW. Kinetic studies of yeast nucleoside diphosphate kinase. Biochem 1969;8(2):633-40
  • Palmieri D, Halverson DO, Ouatas T, et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst 2005;97(9):632-42
  • Ouatas T, Halverson D, Steeg PS, et al. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin Cancer Res 2003;9(10 Pt 1):3763-72
  • Freije JM, Blay P, MacDonald NJ, et al. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997;272(9):5525-32
  • Pozzatti R, Muschel R, Williams J, et al. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 1986;232(4747):223-7
  • Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005;386(3):193-205
  • Morrison DK. KSR: a MAPK scaffold of the Ras pathway J Cell Sci 2001;114(Pt 9):1609-12
  • Salerno M, Palmieri D, Bouadis A, et al. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol Cell Biol 2005;25(4):1379-88
  • Otero AS. NM23/nucleoside diphosphate kinase and signal transduction. J Bioenerg Biomembr 2000;32(3):269-75
  • Biggs J, Hersperger E, Steeg PS, et al. A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 1990;63(5):933-40
  • Pinon VP, Millot G, Munier A et al. Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit. Exp Cell Res 1999;246(2):355-67
  • Eckes B, Dogic D, Colucci-Guyon E, et al. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 1998;111( Pt 13):1897-1907
  • Gilles C, Polette M, Zahm JM, et al. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 1999;112( Pt 24):4615-25
  • Ouatas T, Salerno M, Palmieri D, et al. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 2003;35(1):73-79
  • Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, et al. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol 2005;79(1):42-50
  • Muller W, Schneiders A, Hommel G, et al. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis. Cancer 1998;83(12):2481-7
  • Lee CS, Pirdas A, Lee MW, et al. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi. Pathology 1996;28(3):220-224
  • Kapitanovic S, Cacev T, Berkovic M, et al. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol 2004;57(12):1312-8
  • Zou M, Shi Y, al-Sedairy S, et al. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer 1993;68(2):385-8
  • Ferenc T, Lewinski A, Lange D, et al. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors. Pol J Pathol 2004;55(4):149-53
  • Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8(4):855-65
  • Oda Y, Naka T, Takeshita M, et al. Comparison of histological changes and hanges in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol 2000;31(6):709-16
  • Szumilo J, Skomra D, Chibowski D, et al. Immunoexpression of nm23 in advanced esophageal squamous cell carcinoma. Folia Histochem Cytobiol 2002;40(4):377-80
  • Steeg PS, Palmieri D, Ouatas T, et al. Histidine kinases and histidine phosphorylated proteins in mammalian cell biology, signal transduction and cancer. Cancer Lett 2003;190(1):1-12
  • Besant PG, Attwood PV. Mammalian histidine kinases. Biochim Biophys Acta 2005;1754(1-2):281-90
  • Hartsough MT, Morrison DK, Salerno M, et al. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002;277(35):32389-99
  • Chowdhury D, Beresford PJ, Zhu P, et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006;23(1):133-42
  • Fan Z, Beresford PJ, Oh DY, et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003;112(5):659-72
  • Lieberman J, Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003;15(5):553-9
  • Jackson AL, Loeb LA. The mutation rate and cancer. Genetics 1998;148(4):1483-90
  • Otsuki Y, Tanaka M, Yoshii S, et al. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA 2001;98(8):4385-90
  • Uchida C, Gee E, Ispanovic E, et al. JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 2008;32(7):769-776
  • Boyd PJ, Doyle J, Gee E, et al. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol 2005;288(3):C659-68
  • Ispanovic E, Haas TL. JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 2006;291(4):C579-88
  • Rumjahn SM, Javed MA, Wong N, et al. Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer 2007;97(10):1372-80
  • Moser TL, Kenan DJ, Ashley TA, et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001;98(12):6656-61
  • Subramanian C, Cotter MA, 2nd, Robertson ES, et al. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 2001;7(3):350-5
  • Choudhuri T, Verma SC, Lan K, et al. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 2006;351(1):58-72
  • Elkin M, Orgel A, Kleinman HK, et al. An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 2004;96(11):875-8
  • Fox SB, Leek RD, Smith K, et al. Tumor angiogenesis in node-negative breast carcinomas – relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 1994;29(1):109-16
  • Curtis CD, Likhite VS, McLeod IX, et al. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor α alters estrogen-responsive gene expression. Cancer Res 2007;67(21):10600-7
  • Jung H, Seong HA, Ha H, et al. NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Chem 2007;282(48):35293-307
  • Buck MB, Fritz P, Dippon J, et al. Prognostic significance of transforming growth factor β receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res 2004;10(2):491-8
  • Dumont N, Bakin AV, Arteaga CL, et al. Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 2003;278(5):3275-85
  • Zhu J, Tseng YH, Kantor JD, et al. Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc Natl Acad Sci USA 1999;96(26):14911-8
  • Kim SH, Kim J. Reduction of invasion in human fibrosarcoma cells by ribosomal protein S3 in conjunction with Nm23-H1 and ERK. Biochim Biophys Acta 2006;1763(8):823-32
  • Garzia L, D'Angelo A, Amoresano A, et al. Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene 2008;27(13):1853-64
  • Du J, Hannon GJ. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res 2002;30(24):5465-75
  • Murakami M, Lan K, Subramanian C, et al. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol 2005;79(3):1559-68
  • Seong HA, Jung H, Ha H, et al. NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptor-associated protein, a transforming growth factor-β (TGF-β) receptor-interacting protein, and negatively regulates TGF-β signaling. J Biol Chem 2007;282(16):12075-96
  • D'Angelo A, Garzia L, Andre A, et al. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 2004;5(2):137-49
  • Garzia L, Roma C, Tata N, et al. H-prune-nm23-H1 protein complex and correlation to pathways in cancer metastasis. J Bioenerg Biomembr 2006;38(3-4):205-13

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.